1. 1) Leoni G, Soehnlein O. (Re)solving repair after myocardial infarction. Front Pharmacol., 9, 1342 (2018).
2. 2) Ayoub KF, Pothineni NVK, Rutland J, Ding Z, Mehta JL. Immunity, inflammation, and oxidative stress in heart failure: emerging molecular targets. Cardiovasc. Drugs Ther., 31, 593–608 (2017).
3. 3) Hou L, Guo J, Xu F, Weng X, Yue W, Ge J. Cardiomyocyte dimethylarginine dimethylaminohydrolase1 attenuates left-ventricular remodeling after acute myocardial infarction: involvement in oxidative stress and apoptosis. Basic Res. Cardiol., 113, 28 (2018).
4. 4) van der Pol A, van Gilst WH, Voors AA, van der Meer P. Treating oxidative stress in heart failure: past, present and future. Eur. J. Heart Fail., 21, 425–435 (2019).
5. 5) Torrealba N, Aranguiz P, Alonso C, Rothermel BA, Lavandero S. Mitochondria in structural and functional cardiac remodeling. Adv. Exp. Med. Biol., 982, 277–306 (2017).